Neurobrucellosis

Encephalitis: Diagnosis and Treatment

Volumn , Issue , 2007, Pages 255-272

  Giambartolomei, Guillermo H ^a,b   Wallach, Jorge C ^a   Baldi, Pablo C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77749243235     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Cloeckaert A, Verger JM, Grayon M, et al. Classification of Brucella spp. isolated from marine mammals by DNA polymorphism at the omp2 locus. Microbes Infect 2001; 3(9):729-38.
2. Sohn AH, Probert WS, Glaser CA, et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003; 9(4):485-8.
3. Blasco JM, Diaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 1993; 342 (8874):805.
4. Wallach JC, Samartino L, Efron A, et al. Human infection by Brucella melitensis: An outbreak attributed to contact with infected goats. FEMS Immunol Med Microbiol 1997; 19(4):315-21.
5. Wallach JC, Miguel SE, Goldbaum FA, et al. Urban outbreak of Brucella melitensis in an Argentine family. FEMS Immunol Med Microbiol 1994; 8(1): 49-56.
6. Wallach JC, Giambartolomei GH, Baldi PC, et al. Clinical and immunological features of a human infection by the M-strain of Brucella canis. Emerg Infect Dis 2004; 10(1):146-8.
7. Staszkiewicz J, Lewis CM, Colville J, et al. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol 1991; 29(2):287-90.
8. Kochar DK, Kumawat BL, Agarwal N, et al. Meningoencephalitis in brucellosis. Neurol India 2000; 48(2):170-3.
9. Pappas G, Akritidis N, Bosilkovski M, et al. Brucellosis. N Engl J Med 2005; 352(22):2325-36.
10. Wallach JC, Baldi PC, Fossati CA. Clinical and diagnostic aspects of relapsing meningoencephalitis due to Brucella suis. Eur J Clin Microbiol Infect Dis 2002; 21(10):760-2.
11. Nichols E. Meningo-encephalitis due to brucellosis with the report of a case in which B. abortus was recovered from the cerebrospinal fluid, and a review of the literature. Ann Intern Med 1951; 35(3):673-93.
12. Montes J, Rodriguez MA, Martin T, et al. Laboratory-acquired meningitis caused by Brucella abortus strain 19. J Infect Dis 1986; 154(5):915-6.
13. Bouza E, García de la Torre M, Parras F, et al. Brucellar meningitis. Rev Infect Dis 1987; 9(4):810-22.
14. Dalmau-Ciria M, Tarruella J, Solé Llenas J. Estudio inmunoclínico de la neurobrucelosis. A propó sito de 35 casos. Med Clin Barc 1965; 45(7):387-407.
15. Kaye D. Brucellosis. In: Wilson JD, et al. eds. Harrison’s Principles of Internal Medicine. New York, NY: McGraw-Hill, 1991:625-6.
16. Salata RA, Ravdin JI. Brucella species (brucellosis). In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and Practice of Infectious Diseases. New York, NY: John Wiley & Sons, 1985:1283-90.
17. Habeeb YKR, Al-Najdi AKN, Sadek SAH, et al. Paediatric neurobrucellosis: Case report and literature review. J Infect 1998; 37(1):59-62.
18. Young EJ. Clinical manifestations of human brucellosis. In: Young EJ and Corbel MJ, eds. Brucellosis: Clinical and Laboratory Aspects. Boca Raton, FL: CRC Press, 1989:97-126.
19. Young EJ. Human brucellosis. Rev Infect Dis 1983; 5:821-42.
20. Madkour MM, Al-Moutaery KR, Al-Deeb S, et al. Neurobrucellosis. In: Madkour MM, ed. Madkour’s Brucellosis. 2nd ed. Berlin Heidelberg: Springer-Verlag, 2001:166-78.
21. Debono JE. Brucellosis simulating acute anterior poliomyelitis. Lancet 1964; 13:1132-3.
22. Spink WW. The nature of brucellosis. Minneapolis, MN: University of Minnesota Press, 1956.
23. Shakir RA, Al-Din AS, Araj GF, et al. Clinical categories of neurobrucellosis. A report on 19 cases. Brain 1987; 110(1):213-23.
24. Pedro-Pons A, Foz M, Codina A, Rey C. Les Neurobruceloses (etude de 41 cas). Cahiers de Medecine 1972; 13(11):855-62.
25. Bouza E. Brucelosis cró nica y otras formas clínicas especiales. In: Baquero F, Buzó n L, eds. Encuentro internacional sobre brucelosis. Madrid, 1985: 57-60.
26. Omar FZ, Zuberi S, Minns RA. Neurobrucellosis in childhood: Six new cases and a review of the literature. Dev Med Child Neurol 1997; 39(11):762-5.
27. McLean DR, Russell N, Khan MY. Neurobrucellosis: Clinical and therapeutic features. Clin Infect Dis 1992; 15(4):582-90.
28. Hughes ML. Mediterranean, Malta or Undulant fever. London: Mac Millan; 1897:124.
29. Lemaire MG. Meningite a melitocoques alterations importantes du liquide cephalo-rachidien. Bull Memories Soc Med Hosp Paris 1924; 48:1636.
30. Galle C, Struelens M, Liesnard C, et al. Brucella melitensis osteitis following craniotomy in a patient with AIDS. Clin Infect Dis 1997; 24(5):1012.
31. Puri P, Harvey TW. Colonisation of ventriculoatrial shunt with Brucella abortus. Br Med J (Clin Res Ed) 1981; 282(6278):1754-5.
32. Chowdhary UM, Twum-Danso K. Brucella meningoencephalitis associated with cerebrospinal fluid shunt in a child: Case report. Surg Neurol 1991; 35(6): 468-70.
33. Sanchez Novials A, Capdevila Morell JA, Miquel Rodriguez F, et al. Brucellar meningitis in the differential diagnosis of clear-fluid meningitis. Rev Clin Esp 1981; 161(1):49-54.
34. Rangel Guerra R, Martinez HR, de Leon Flores L. Neurobrucellosis. Report of five cases and literature review. Rev Invest Clin 1982; 34(1):62-8.
35. Martinez-Chamorro E, Muñoz A, Esparza J, et al. Focal cerebral involvement by neurobrucellosis: Pathological and MRI findings. Eur J Radiol 2002; 43(1): 28-30.
36. Thomas R, Kameswaran M, Murugan V, Okafor BC. Sensory neural hearing loss in neurobrucellosis. J Laryngol Otol 1993; 107(11):1034-6.
37. Roldan-Montaud A, Jimenez-Jimenez FJ, Zancada F. Neurobrucellosis mimicking migraine. Eur Neurol 1991; 31(1):30-2.
38. Abd Elrazak M. Brucella optic neuritis. Arch Intern Med 1991; 151(4):776-8.
39. Guerrero Espejo A. Neurobrucelosis. In: Baquero F, Buzó n L, eds. Encuentro Internacional sobre Brucelosisa, ed. rev. Editorial Garsi S.A., Madrid, 1985: 83-8
40. Omasits M, Brainin M. Primary chronic neurobrucellosis. Fortschr Neurol Psychiatr 1987; 55(10):291-3.
41. Al-Eissa YA, Al-Herbish AS. Severe hypertension: An unusual presentation of Guillain-Barré syndrome in a child with brucellosis. Eur J Pediatr 1996; 155: 53-5.
42. Al Deeb SM, Yaqub BA, Sharif HS, Phadke JG. Neurobrucellosis: Clinical characteristics, diagnosis, and outcome. Neurology 1989; 39(4): 498-501.
43. Oliveri RL, Matera G, Foca` A, et al. Polyradiculoneuropathy with cerebrospinal fluid albuminocytological dissociation due to neurobrucellosis. Clin Infect Dis 1996; 23(4):833-4.
44. Namiduru M, Karaoglan I, Yilmaz M. Guillain-Barre syndrome associated with acute neurobrucellosis. Int. J Clin Pract 2003; 57(1):919-20.
45. Shoshan Y, Maayan S, Gomori MJ, Israel Z. Chronic subdural empyema: A new presentation of neurobrucellosis. Clin Infect Dis 1996; 23(2):400-1.
46. Montejo F, Merino J, Alberola I, et al. Absceso epidural bruceló sico. Med Clin (Barc) 1983; 80(4):187-8.
47. Bussone G, La Mantia L, Grazzi L, et al. Neurobrucellosis mimicking multiple sclerosis: A case report. Eur Neurol 1989; 29(4): 238-40.
48. Murrell TG, Matthews BJ. Multiple sclerosis-one manifestation of neurobrucellosis? Med Hypotheses 1990; 33(1):43-8.
49. Sheikh KA, Ho TW, Nachamkin I, et al. Molecular mimicry in Guillain-Barré syndrome. Ann NY Acad Sci 1998; 845:307-21.
50. Drevets DA, Leenen PJM, Greenfield RA. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev 2004; 17(2):323-47.
51. Giambartolomei GH, Zwerdling A, Cassataro J, et al. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol 2004; 173(4):4635-42.
52. Ramesh G, Alvarez AL, Roberts ED, et al. Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol 2003; 33(9): 2539-50.
53. Seidel G, Pardo CA, Newman-Toker D, et al. Neurobrucellosis presenting as leukoencephalophaty The role of cytotoxic T lymphocytes. Arch Pathol Lab Med 2003; 127(9):374-7.
54. Krishnan C, Kaplin AI, Graber JS, et al. Recurrent transverse myelitis following neurobrucellosis: Immunologic features and beneficial response to immunosuppression. J Neurovirol 2005; 11(2):225-31.
55. Mense MG, Borschel RH, Wilhelmsen CL, et al. Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta). Am J Vet Res 2004; 65(5):644-52.
56. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Ex Med 1993; 178(5):1771-5.
57. Moran AP, Prendergast MM. Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barré syndrome. J Infect Dis 1998; 178(5):1549-50.
58. Rees J, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333(21):1374-9.
59. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guiilain-Barré syndrome. Proc Natl Acad Sci USA 2004; 101(31): 11404-9.
60. Watanabe K, Kim S, Nishiguchi M, et al. Brucella melitensis infection associated with Guillain-Barre syndrome through molecular mimicry of host structures. FEMS Immunol Med Microbiol 2005; 45(2):121-7.
61. Kochar DK, Agarwal N, Jain N, et al. Clinical profile of neurobrucellosis-a report on 12 cases from Bikaner (north-west India). J Assoc Physicians India 2000; 48(4):376-80.
62. Akhtar M. Histopathological features. In: Madkour MM, ed. Madkour’s Brucellosis. 2nd ed. Berlin Heidelberg: Springer-Verlag, 2001:65-73.
63. Fincham RW, Sahs AL, Joint RJ. Protean manifestations of nervous system brucellosis. Case histories of a wide variety of clinical forms. JAMA 1963; 184: 269-75.
64. Özisik HI, Ersoy Y, Tevfik MR, et al. Isolated intracranial hypertension: A rare presentation of neurobrucellosis. Microbes Infect 2004; 6(9):861-3.
65. Silva CA, Río ME, Maia Gonçalves A. Oligoclonal gamma-globulin in cerebrospinal fluid in neurobrucellosis. Acta Neurol Scand 1980; 61(1):42-8.
66. Akdeniz H, Irmak H, Anlar Ö, et al. Central nervous system brucellosis: Presentation, diagnosis and treatment. J Infect 1998; 36(3):297-301.
67. Da Cunha S, Gaspar E, Meliço-Silvestre A, et al. Neurobrucellosis: Another cause of increased adenosine deaminase activity in cerebrospinal fluid. J Infect Dis 1990; 161(1):156-7.
68. Young EJ. Brucella species. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases. London: Churchill Livingstone, 2000:2386-93.
69. Araj GF, Lulu AR, Khateeb MI, et al. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS 1988; 96(2): 171-6.
70. Araj GF. Enzyme-linked immunosorbent assay, not agglutination, is the test of choice for the diagnosis of neurobrucellosis. Clin Infect Dis 1997; 25(4):942.
71. Diaz R, Maraví-Poma E, Delgado G, et al. Rose Bengal plate agglutination and counter immunoelectrophoresis tests on spinal fluid in the diagnosis of Brucella meningitis. J Clin Microbiol 1978; 7(2):236-7.
72. Sanchez-Sousa A, Torres C, Campello MG, et al. Serological diagnosis of neurobrucellosis. J Clin Pathol 1990; 43(1):79-81.
73. Corbel MJ. Recent advances in the study of Brucella antigens and their serological cross-reactions. Vet Bull 1985; 55:927-42.
74. Perry M, Bundle D. Lipopolysaccharide antigens and carbohydrates of Brucella. In: Adams LG ed. Advances in Brucellosis Research. College Station, Texas: Texas A&M University Press, 1990:76-88.
75. Diaz R, Moriyó n I. Laboratory techniques in the diagnosis of human brucellosis. In: Young EJ, Corbel MJ, eds. Brucellosis: Clinical and Laboratory Aspects. Boca Raton, FL: CRC Press, 1989:73-83.
76. Goldbaum FA, Rubbi CP, Wallach JC, et al. Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses. J Clin Microbiol 1992; 30(3):604-7.
77. Zygmunt MS, Martin JC, Dubray G. Analysis of immune response: Comparison of immunoblots after isoelectric focusing and sodium dodecyl sulfate-polyacrylamide gel electrophoresis using cytoplasmic protein extract from Brucella. FEMS Microbiol Lett 1990; 58(3):263-8.
78. Baldi PC, Miguel SE, Fossati CA, et al. Serological follow-up of human brucellosis by measuring IgG antibodies directed to LPS and cytoplasmic proteins of Brucella. Clin Infect Dis 1996; 22(3):446-55.
79. Baldi PC, Araj GF, Racaro GC, Wallach JC, Fossati CA. Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis. Clin Diagn Lab Immunol 1999; 6(5):756-9.
80. Navarro E, Casao MA, Solera J. Diagnosis of human brucellosis using PCR. Expert Rev Mol Diagn 2004; 4(1):115-23.
81. Morata P, Queipo-Ortuño MI, Reguera JM, et al. Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol 2001; 39(10): 3743-6.
82. Diaz Espejo CE, Villalobos Chaves F, Sureda Ramis B. Chronic intracranial hypertension secondary to neurobrucellosis. J Neurol 1987; 234(1):51-61.
83. Solaroglu I, Kaptanoglu E, Okutan O, et al. Solitary extra-axial posterior fossa abscess due to neurobrucellosis. J Clin Neurosci 2003; 10(6):710-2.
84. Kizilkilic O, Turunc T, Yildirim T, et al. Successful medical treatment of intracranial abscess caused by Brucella spp. J Infect 2005; 51(1):77-80.
85. Trifiletti RR, Restivo DA, Pavone P, et al. Diabettes insipidus in neurobrucellosis (case report). Clin Neurol and Neurosurg 2000; 102(3):163-5.
86. Hall WH. Modern chemotheraphy for brucellosis in humans. Rev Infect Dis 1990; 12(6):1060-99.